Access cutting-edge aortic stenosis treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access aortic stenosis specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related aortic stenosis treatment provided free
This is an adaptive Phase 2/3 multicenter, double-blind, placebo-controlled, randomized, parallel, 2 arm study to evaluate the efficacy and safety of DA-1229 compared to placebo in patients with calcific aortic valve disease with mild to moderate aortic stenosis. There are 2 arms in this study to which patients will be randomized in a ratio of 1:1 to receive the DA-1229 or placebo orally once daily for a period of 104 weeks. The 2 arms are: placebo and DA-1229 10 mg Group. The study will have t
Sponsor: REDNVIA Co., Ltd.
Check if you qualify for this aortic stenosis clinical trial in Phoenix, AZ
If you're searching for aortic stenosis treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced aortic stenosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.